MAIA Biotechnology, Inc.
AMEX:MAIABiotechnology
+$0.05 today
- Market cap
- $80.28M
- Beta
- 0.24
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.76
Volume 2.25M
Average 0.78M
MAIA Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How MAIA compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Dec 2025 | -345.4% | -238.7 pp | -424.7 pp | |
| LTM Mar 2026 | -824.0% | +3408.5 pp | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding MAIA) | -584.7% | +1584.9 pp | -424.7 pp | |
Competitors are the stored peer set for MAIA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 3.45M | 8.93M | 11.11M | 10.01M | 14.55B |
| Selling, General & Admin | 4.29M | 6.14M | 9.07M | 6.95M | 9.72B |
| Operating Expenses | 7.79M | 16.18M | 20.18M | 16.96M | 24.27M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| EBITDA | (11.75M) | (15.76M) | (19.77M) | (23.25M) | (22.4M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (7.79M) | (16.18M) | (20.18M) | (16.96M) | (24.27M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 2.01K | 1.87K | 27.63K | 318.37K | 313.95K |
| Interest Expense | 827.54K | 6.97K | 0 | 57 | 0 |
| Other Income / Expenses | (4.79M) | 406.92K | 409.48K | (6.3M) | 1.87M |
| Income Before Tax | (12.58M) | (15.77M) | (19.77M) | (23.25M) | (22.4M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (12.5M) | (15.77M) | (19.77M) | (23.25M) | (22.4M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.18) | (1.70) | (1.49) | (1.05) | (0.70) |
| EPS (Diluted) | (1.18) | (1.70) | (1.49) | (1.05) | (0.70) |
| Weighted Avg Shares | 10.64M | 9.28M | 13.26M | 22.2M | 32.12M |
| Weighted Avg Shares (Diluted) | 10.64M | 9.28M | 13.26M | 22.2M | 32.12M |
MAIA Biotechnology, Inc.
AMEX:MAIA
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.